Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACET |
---|---|---|
09:32 ET | 2380 | 1.885 |
09:34 ET | 26665 | 1.895 |
09:36 ET | 8682 | 1.845 |
09:38 ET | 1501 | 1.835 |
09:39 ET | 10966 | 1.825 |
09:41 ET | 1600 | 1.825 |
09:43 ET | 2354 | 1.84 |
09:45 ET | 1400 | 1.84 |
09:48 ET | 9624 | 1.83 |
09:50 ET | 8911 | 1.84 |
09:52 ET | 1094 | 1.86 |
09:56 ET | 10401 | 1.88 |
09:57 ET | 1300 | 1.89 |
09:59 ET | 12247 | 1.905 |
10:01 ET | 19190 | 1.905 |
10:03 ET | 700 | 1.905 |
10:06 ET | 7824 | 1.915 |
10:08 ET | 676 | 1.92 |
10:10 ET | 8301 | 1.93 |
10:12 ET | 7645 | 1.95 |
10:14 ET | 3652 | 1.945 |
10:15 ET | 7453 | 1.92 |
10:17 ET | 126 | 1.915 |
10:19 ET | 1000 | 1.91 |
10:21 ET | 800 | 1.9 |
10:24 ET | 1232 | 1.905 |
10:26 ET | 6838 | 1.88 |
10:28 ET | 3558 | 1.89 |
10:30 ET | 9527 | 1.86 |
10:32 ET | 955 | 1.865 |
10:33 ET | 11769 | 1.875 |
10:35 ET | 1258 | 1.87 |
10:37 ET | 700 | 1.86 |
10:39 ET | 10031 | 1.875 |
10:42 ET | 1158 | 1.87 |
10:44 ET | 3952 | 1.87 |
10:46 ET | 1263 | 1.865 |
10:48 ET | 1003 | 1.865 |
10:50 ET | 2816 | 1.865 |
10:51 ET | 558 | 1.86 |
10:53 ET | 3956 | 1.87 |
10:55 ET | 3518 | 1.875 |
10:57 ET | 454 | 1.875 |
11:00 ET | 1600 | 1.875 |
11:02 ET | 3418 | 1.875 |
11:04 ET | 10566 | 1.87 |
11:06 ET | 2950 | 1.86 |
11:08 ET | 1956 | 1.8493 |
11:09 ET | 754 | 1.845 |
11:11 ET | 1853 | 1.845 |
11:13 ET | 1100 | 1.85 |
11:15 ET | 1571 | 1.845 |
11:18 ET | 1702 | 1.845 |
11:20 ET | 2400 | 1.845 |
11:22 ET | 5354 | 1.85 |
11:24 ET | 10692 | 1.86 |
11:26 ET | 4522 | 1.855 |
11:27 ET | 1436 | 1.85 |
11:29 ET | 1218 | 1.855 |
11:31 ET | 3636 | 1.84 |
11:33 ET | 5463 | 1.835 |
11:36 ET | 23118 | 1.82 |
11:38 ET | 700 | 1.82 |
11:40 ET | 2036 | 1.825 |
11:42 ET | 11583 | 1.825 |
11:44 ET | 200 | 1.825 |
11:45 ET | 7363 | 1.825 |
11:47 ET | 400 | 1.825 |
11:49 ET | 1313 | 1.8299 |
11:51 ET | 1118 | 1.82 |
11:54 ET | 6218 | 1.8225 |
11:56 ET | 8181 | 1.835 |
11:58 ET | 248 | 1.835 |
12:00 ET | 3041 | 1.845 |
12:03 ET | 448 | 1.85 |
12:05 ET | 4700 | 1.85 |
12:07 ET | 2472 | 1.85 |
12:09 ET | 3138 | 1.86 |
12:12 ET | 4132 | 1.855 |
12:14 ET | 748 | 1.85 |
12:16 ET | 1696 | 1.85 |
12:20 ET | 1196 | 1.84 |
12:21 ET | 1796 | 1.845 |
12:23 ET | 1444 | 1.85 |
12:25 ET | 1348 | 1.84 |
12:27 ET | 1090 | 1.85 |
12:30 ET | 200 | 1.845 |
12:32 ET | 1751 | 1.845 |
12:34 ET | 1893 | 1.845 |
12:36 ET | 200 | 1.845 |
12:38 ET | 554 | 1.84 |
12:39 ET | 800 | 1.845 |
12:41 ET | 300 | 1.85 |
12:43 ET | 400 | 1.84 |
12:45 ET | 700 | 1.845 |
12:48 ET | 700 | 1.85 |
12:50 ET | 772 | 1.8425 |
12:52 ET | 1100 | 1.85 |
12:54 ET | 979 | 1.845 |
12:56 ET | 400 | 1.84 |
12:57 ET | 13709 | 1.85 |
01:01 ET | 500 | 1.855 |
01:03 ET | 2285 | 1.855 |
01:06 ET | 486 | 1.84 |
01:08 ET | 1534 | 1.85 |
01:10 ET | 2559 | 1.845 |
01:12 ET | 2729 | 1.82 |
01:14 ET | 500 | 1.825 |
01:15 ET | 400 | 1.825 |
01:17 ET | 1067 | 1.8201 |
01:19 ET | 400 | 1.82 |
01:21 ET | 200 | 1.825 |
01:24 ET | 1700 | 1.815 |
01:26 ET | 500 | 1.815 |
01:28 ET | 300 | 1.81 |
01:30 ET | 7641 | 1.81 |
01:32 ET | 200 | 1.81 |
01:33 ET | 2439 | 1.825 |
01:35 ET | 310 | 1.825 |
01:39 ET | 300 | 1.8293 |
01:42 ET | 400 | 1.83 |
01:44 ET | 500 | 1.82 |
01:46 ET | 5479 | 1.835 |
01:48 ET | 750 | 1.84 |
01:50 ET | 300 | 1.84 |
01:51 ET | 800 | 1.84 |
01:53 ET | 400 | 1.84 |
01:55 ET | 8514 | 1.85 |
01:57 ET | 800 | 1.8499 |
02:00 ET | 6138 | 1.835 |
02:02 ET | 5994 | 1.845 |
02:04 ET | 3010 | 1.8403 |
02:06 ET | 900 | 1.845 |
02:08 ET | 1000 | 1.84 |
02:09 ET | 700 | 1.845 |
02:11 ET | 300 | 1.845 |
02:13 ET | 1600 | 1.845 |
02:15 ET | 600 | 1.84 |
02:18 ET | 800 | 1.845 |
02:20 ET | 1800 | 1.85 |
02:22 ET | 300 | 1.84 |
02:24 ET | 2200 | 1.845 |
02:26 ET | 1228 | 1.845 |
02:27 ET | 1433 | 1.84 |
02:29 ET | 6423 | 1.84 |
02:31 ET | 4382 | 1.82 |
02:33 ET | 700 | 1.82 |
02:36 ET | 1047 | 1.825 |
02:38 ET | 700 | 1.82 |
02:40 ET | 7338 | 1.81 |
02:42 ET | 600 | 1.81 |
02:44 ET | 600 | 1.815 |
02:45 ET | 400 | 1.815 |
02:47 ET | 1664 | 1.81 |
02:49 ET | 500 | 1.815 |
02:51 ET | 300 | 1.815 |
02:54 ET | 23087 | 1.835 |
02:56 ET | 1862 | 1.8377 |
03:00 ET | 950 | 1.835 |
03:02 ET | 370 | 1.835 |
03:03 ET | 200 | 1.836 |
03:05 ET | 1193 | 1.835 |
03:07 ET | 1293 | 1.835 |
03:09 ET | 3092 | 1.84 |
03:12 ET | 2057 | 1.835 |
03:14 ET | 3652 | 1.835 |
03:16 ET | 1300 | 1.84 |
03:18 ET | 1854 | 1.835 |
03:20 ET | 4262 | 1.85 |
03:21 ET | 2466 | 1.85 |
03:23 ET | 32283 | 1.86 |
03:25 ET | 4535 | 1.85 |
03:27 ET | 200 | 1.845 |
03:30 ET | 400 | 1.845 |
03:32 ET | 799 | 1.845 |
03:34 ET | 11823 | 1.83 |
03:36 ET | 1900 | 1.835 |
03:38 ET | 3192 | 1.835 |
03:39 ET | 15135 | 1.825 |
03:41 ET | 3316 | 1.825 |
03:43 ET | 3204 | 1.815 |
03:45 ET | 21264 | 1.81 |
03:48 ET | 5181 | 1.82 |
03:50 ET | 7717 | 1.83 |
03:52 ET | 3100 | 1.83 |
03:54 ET | 9350 | 1.83 |
03:56 ET | 8666 | 1.825 |
03:57 ET | 15807 | 1.82 |
03:59 ET | 79799 | 1.81 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Adicet Bio Inc | 154.0M | -0.5x | --- |
Achieve Life Sciences Inc | 155.5M | -3.0x | --- |
Aeon Biopharma Inc | 151.5M | -4.3x | --- |
Gossamer Bio Inc | 159.8M | -0.5x | --- |
Cytodyn Inc | 147.5M | -2.7x | --- |
Greenwich Lifesciences Inc | 162.5M | -17.8x | --- |
Adicet Bio, Inc. is a clinical stage biotechnology company. The Company is engaged in advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma (NHL). Its pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications. Its pipeline has several additional internal gamma delta T cell therapy programs in discovery and preclinical development for both hematological malignancies and solid tumors.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $154.0M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 82.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.89 |
EPS | $-3.32 |
Book Value | $3.93 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.